Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.5M Buy
203,651
+1,792
+0.9% +$207K 0.83% 27
2025
Q4
$21.2M Buy
201,859
+417
+0.2% +$39.1K 0.71% 33
2025
Q3
$16.9M Buy
201,442
+5,096
+3% +$420K 0.58% 43
2025
Q2
$15.5M Sell
196,346
-5,303
-3% -$422K 0.58% 45
2025
Q1
$18.1M Sell
201,649
-7,067
-3% -$660K 0.73% 35
2024
Q4
$20.8M Buy
208,716
+9,640
+5% +$994K 0.78% 29
2024
Q3
$22.6M Sell
199,076
-1,878
-0.9% -$223K 0.87% 28
2024
Q2
$24.9M Sell
200,954
-3,525
-2% -$454K 1.02% 18
2024
Q1
$27M Sell
204,479
-2,777
-1% -$342K 1.1% 16
2023
Q4
$22.6M Sell
207,256
-15,739
-7% -$1.63M 0.99% 19
2023
Q3
$23M Sell
222,995
-26,380
-11% -$2.84M 1.1% 20
2023
Q2
$28.8M Buy
249,375
+64,209
+35% +$7.29M 1.33% 14
2023
Q1
$19.7M Sell
185,166
-3,125
-2% -$337K 1.05% 22
2022
Q4
$20.9M Buy
188,291
+331
+0.2% +$33.8K 1.1% 22
2022
Q3
$16.2M Buy
187,960
+6,401
+4% +$571K 0.94% 24
2022
Q2
$16.6M Sell
181,559
-2,371
-1% -$210K 0.93% 25
2022
Q1
$15.1M Buy
183,930
+12,560
+7% +$990K 0.78% 35
2021
Q4
$13.1M Sell
171,370
-1,462
-0.8% -$116K 0.69% 39
2021
Q3
$13M Sell
172,832
-3,058
-2% -$233K 0.78% 34
2021
Q2
$13.7M Sell
175,890
-16,967
-9% -$1.26M 0.83% 31
2021
Q1
$14.2M Sell
192,857
-28,000
-13% -$2.07M 0.93% 24
2020
Q4
$17.2M Sell
220,857
-3,735
-2% -$286K 1.19% 16
2020
Q3
$17.8M Buy
224,592
+669
+0.3% +$52.4K 1.38% 11
2020
Q2
$16.5M Buy
223,923
+4,704
+2% +$354K 1.4% 11
2020
Q1
$16.1M Buy
219,219
+1,511
+0.7% +$119K 1.61% 10
2019
Q4
$18.9M Sell
217,708
-1,112
-0.5% -$91.3K 1.54% 13
2019
Q3
$17.6M Buy
218,820
+229
+0.1% +$18.4K 1.58% 12
2019
Q2
$17.5M Sell
218,591
-3,394
-2% -$260K 1.63% 10
2019
Q1
$17.6M Sell
221,985
-3,088
-1% -$231K 1.76% 9
2018
Q4
$16.4M Buy
225,073
+961
+0.4% +$67.8K 1.83% 7
2018
Q3
$15.2M Buy
224,112
+1,790
+0.8% +$114K 1.54% 12
2018
Q2
$12.9M Buy
222,322
+4,690
+2% +$265K 1.42% 13
2018
Q1
$11.3M Buy
217,632
+4,524
+2% +$244K 1.29% 14
2017
Q4
$11.4M Sell
213,108
-3,153
-1% -$175K 1.26% 18
2017
Q3
$13.2M Buy
216,261
+4,644
+2% +$282K 1.53% 12
2017
Q2
$12.9M Buy
211,617
+6,601
+3% +$402K 1.58% 10
2017
Q1
$12.4M Sell
205,016
-589
-0.3% -$35.7K 1.61% 10
2016
Q4
$11.5M Buy
205,605
+280
+0.1% +$16.4K 1.63% 11
2016
Q3
$12.2M Sell
205,325
-1,110
-0.5% -$64.9K 1.84% 9
2016
Q2
$11.3M Sell
206,435
-4,774
-2% -$254K 1.74% 9
2016
Q1
$10.7M Buy
211,209
+6,050
+3% +$296K 1.63% 9
2015
Q4
$10.3M Buy
205,159
+3,467
+2% +$175K 1.64% 9
2015
Q3
$9.51M Buy
201,692
+5,440
+3% +$289K 1.63% 8
2015
Q2
$10.7M Buy
196,252
+6,145
+3% +$345K 1.71% 5
2015
Q1
$10.4M Buy
190,107
+15,257
+9% +$864K 1.78% 6
2014
Q4
$9.47M Buy
174,850
+4,770
+3% +$266K 1.69% 8
2014
Q3
$9.62M Buy
170,080
+5,215
+3% +$293K 1.82% 6
2014
Q2
$9.1M Buy
164,865
+12,556
+8% +$685K 1.76% 7
2014
Q1
$8.25M Buy
152,309
+6,548
+4% +$339K 1.48% 11
2013
Q4
$6.96M Buy
145,761
+2,297
+2% +$105K 1.27% 14
2013
Q3
$6.52M Buy
143,464
+7,369
+5% +$336K 1.28% 13
2013
Q2
$6.03M Buy
+136,095
New +$6.08M 1.24% 15

Other funds holding MRK

First National Trust's MRK Position: Q1 2026 in Review

First National Trust increased its Merck (MRK) stake by 0.89% in Q1 2026, buying an estimated $207K and bringing the position to 203,651 shares worth $24.5M. The position accounts for 0.83% of the portfolio, ranked #27.

First National Trust first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $28.8M in Q2 2023. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • First National Trust held 203,651 shares of Merck worth $24.5M as of Q1 2026.
  • First National Trust bought 1,792 Merck shares in Q1 2026, an estimated $207K.
  • Merck made up 0.83% of First National Trust's portfolio in Q1 2026, its #27 holding.
  • First National Trust first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • First National Trust's Merck position peaked at $28.8M in Q2 2023.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on First National Trust's 13F filing for Q1 2026, filed 7 May 2026.